Ask any fashionable woman for her go-to pair of jeans when she wants to look smart, and I can guarantee she’ll point you in the direction of a rich, dark-blue was. Sleeker than lighter washes and ...

The Toronto Blue Jays have had a hectic and successful offseason so far, but there is still some work to be done and a looming question to answer. Coming into the winter, the Blue Jays had a desire to ...

Bo Bichette was a key player for the Toronto Blue Jays last season. However, they may not see him as a priority in free agency after signing Kazuma Okamoto. The Athletic's Mitch Bannon has noted that ...

The acquisition will enable Amgen to further its research and improve the development of cancer-targeting treatments. US multinational biotechnology company Amgen has announced the acquisition of ...

Amgen AMGN announced that it has acquired U.K.-based private biotech company, Dark Blue Therapeutics, for approximately $840 million. The acquisition will strengthen Amgen’s oncology pipeline by ...

Amgen has agreed to acquire UK-based biotech Dark Blue Therapeutics for up to $840m, making it the first pharma takeover of 2026. Through this transaction, Amgen will gain access to Dark Blue’s ...

Lead candidate in the MLLT1/3 programme, DBT 3757, is a differentiated investigational molecule designed to treat Acute Myeloid Leukemia Acquisition brings a new therapeutic mechanism to Amgen's ...

Amgen is adding Dark Blue to its tapestry, embedding the U.K. biotech’s preclinical blood cancer program into its organization. The California pharma has stitched together a deal worth up to $840 ...

The company plans to integrate Dark Blue Therapeutics into its existing research organization to strengthen its early oncology discovery efforts. With annual revenue of nearly $36 billion and healthy ...